| ALMIRALL S.A. | 11,5400 / -2,37% |
| 日期/时间 | 22.01. / 17:35 |
| 涨跌。 / 涨跌。(%) | -0,2800 / -2,37% |
| Bid | 11,5000 / 60 |
| Ask | 11,7500 / 250 |
| 打开 | 11,7800 |
| 以往收市 | 11,8200 |
| 高 | 11,7800 |
| 低 | 11,4300 |
| 成交量 [EUR] | 4.464.891,6800 |
| 成交量 [Units] | 386.382 |
| Price fixings | 1391 |
| ISIN | ES0157097017 |
| 符号 | ALM |
| 交易所 | Madrid |
| 类型 | 股票 |
所有交易
| 交易所 | 最后的 | 成交量 | |
|---|---|---|---|
| Lang & Schwa.. | 11,450 |  |
|
| Madrid | 11,5400 |  |
386.382 |
| Cboe Europe .. | 11,56 | |
27.125 |
| London Inter.. | 11,46 | |
20.371 |
| Turquoise | 11,56 | |
2.216 |
| Frankfurt | 11,7100 | |
0 |
| Berlin | 11,700 | |
0 |
| Stuttgart | 11,600 | |
0 |
| TradeGate | 11,94 | 237 | |
| Cboe Europe .. | 12,00 | 370 | |
| Cboe Europe .. | 12,01 | 150 | |
| Nasdaq Other.. | 12,4000 | 1.087 |
新闻
- Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
06.01.2021 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
04.01.2021 / 23:00 - GlobeNewswire - Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
15.12.2020 / 13:00 - GlobeNewswire - Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
08.12.2020 / 14:13 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01.12.2020 / 22:05 - GlobeNewswire